Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03225651
Other study ID # VinmecRISCGT69
Secondary ID
Status Completed
Phase Phase 2
First received
Last updated
Start date July 18, 2017
Est. completion date August 30, 2019

Study information

Verified date November 2018
Source Vinmec Research Institute of Stem Cell and Gene Technology
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study was to evaluate the safety and effectiveness of autologous bone marrow mononuclear stem cells combined with Psychological Therapy and Rehabilitation for Autism children


Description:

The aim of this study was to evaluate the safety and effectiveness of autologous bone marrow mononuclear stem cells combined with Psychological Therapy and Rehabilitation in the management of autism of 60 patients at Vinmec Research Institute of Stem Cell and Gene Technology Hanoi, Vietnam from January 2017 to December 2018


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date August 30, 2019
Est. primary completion date August 30, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 3 Years to 7 Years
Eligibility Inclusion Criteria:

- Confirmed diagnosis of autism according to the Diagnostic and Statistical Manual-V diagnostic criteria for autistic disorder

Exclusion Criteria:

- Epilepsy

- Hydrocephalus with ventricular drain

- Coagulation disorders

- Allergy to anesthetic agents

- Severe health conditions such as cancer, failure of heart, lung, liver or kidney

- Active infections

- Severe psychiatric disorders

- Rett syndrome

- Fragile X syndrome

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
Stem cell transplantation
Transplantation of Autologous Bone Marrow Mononuclear cells
Behavioral:
Psychological therapy and Rehabilitation
Psychological Therapy and Rehabilitation for autism children around 3 months

Locations

Country Name City State
Vietnam Vinmec Research Institute of Stem Cell and Gene Technology Hanoi

Sponsors (1)

Lead Sponsor Collaborator
Vinmec Research Institute of Stem Cell and Gene Technology

Country where clinical trial is conducted

Vietnam, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assess the change in autism level by using tools using total score of childhood autism rating scale, autism diagnostic observation schedule second edition, DENVER II, Indian Scale for assessment of Autism 6 months and 12 months after transplantation
Primary Evaluate the safety of therapy by record number of adverse events Through study completion, an average of 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT03918343 - Lipopolysaccharide Metabolism and Identification of Potential Biomarkers Predictive of Graft-versus-host Disease After Allogeneic Stem Cell Transplantation N/A
Not yet recruiting NCT05438823 - Technology Supported Education Program Based on Human Care Theory N/A
Not yet recruiting NCT02193399 - Physiotherapy in Hematopoietic Stem Cell Transplantation N/A
Withdrawn NCT00972101 - Infusion of Expanded Cord Blood T Cells Phase 1
Completed NCT05421299 - A Study to Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Abatacept in Combination With a Calcineurin Inhibitor and Methotrexate
Completed NCT04976933 - Post-HSCT Medication Adherence mHealth App
Completed NCT04798495 - Feasibility of a Rehabilitation Programme Targeted Patients Treated With Non-myeloablative Stem Cell Transplantation N/A
Completed NCT00612274 - Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute GVHD in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation Phase 0
Active, not recruiting NCT04511130 - Efficacy of MT-401 in Patients With AML Following Stem Cell Transplant Phase 2
Recruiting NCT05968963 - Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation N/A
Recruiting NCT02940093 - Pipeline Integrating Gut Metagenome Data, Host Immunogenetic Characteristics and Clinical Gut Inflammatory Biomarkers N/A
Not yet recruiting NCT06077734 - Muscle Stem Cell Quality in Atrophy
Terminated NCT00587990 - Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) Phase 1/Phase 2
Terminated NCT00597441 - Phase I Study of Umbilical Cord Blood Transplantation Followed by Third Party Thymus Transplantation Phase 1
Active, not recruiting NCT03684083 - Inflammatory Response to Paramyxovirus Infection in an Ex-vivo Model of Bronchial Epithelial Cells in Allogeneic HSCT Recipients
Recruiting NCT00884338 - Cognitive Function After Stem Cell Transplantation Phase 3
Completed NCT00284713 - Progenitor Cell Therapy in Dilative Cardiomyopathy Phase 1/Phase 2
Withdrawn NCT00062543 - Hepatic Artery Infusion of CD34+ Cells Phase 1
Completed NCT00781170 - Dose-Reduced Allogeneic Stem Cell Transplantation After Autologous High-Dose Chemotherapy in Patients With Multiple Myeloma Phase 2
Recruiting NCT03364257 - iDTECT Blood Performance for the Identification of Viral or Bacterial Pathogens in Febrile Neutropenic Patients